|Articles|February 1, 2020
- BioPharm International-02-01-2020
- Volume 33
- Issue 2
BioPharm International, February 2020 Issue (PDF)
Click the title above to open the BioPharm International February 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Managing Risk for Cell and Gene Therapy Logisticsalmost 6 years ago
The Call for a Rapid Responsealmost 6 years ago
Data Management Practicesalmost 6 years ago
Biopharma Analysis Benefits from New Technology and Methodsalmost 6 years ago
Cell Therapies: The Living End of Growth Opportunitiesalmost 6 years ago
Fresh Thinking in Biologic Drug Formulationalmost 6 years ago
The Need for Advanced Process Modeling for New Therapeutic Biologicsalmost 6 years ago
Cell Culture Variables for Gene Therapy Vectorsalmost 6 years ago
Challenges in Vector Purification for Gene TherapyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
2
China Approves First Monthly Biologic for COPD
3
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
4
FUJIFILM Irvine Scientific Rebrands as FUJIFILM Biosciences
5
